Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

149.06 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Peering Into AbbVie's Recent Short Interest
Via Benzinga
3 Biotech Stocks for Getting Rich in 2023
These 3 biotech stocks have seen stable or growing revenue this year. This makes them companies to keep on your watchlist. 
Via InvestorPlace
BeiGene's Brukinsa Positioned as Preferred BTK Inhibitor: Analyst Says Survey Supports Bullish View
Citi initiated coverage on BeiGene Ltd (NASDAQ: BGNE) with a price target of $275 and a B 
Via Benzinga
MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022
MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for... 
Via Benzinga
3 Dividend Stocks That Still Make Sense in 2023
Investors are still faced with an uncertain market which is favorable for these three dividend stocks regardless of what happens in the economy 
Via MarketBeat
Topics Economy
Exposures Economy
AbbVie Inc. (NYSE: ABBV) Highlighted for Surprising Price Action
Via Investor Brand Network
Analyst Ratings for AbbVie
Via Benzinga
AbbVie Unusual Options Activity For July 12
Via Benzinga
Check Out What Whales Are Doing With ABBV
Via Benzinga
3 Dividend Growth Stocks to Buy and Hold
Where these dividends are going is even more important than where they've been. 
Via The Motley Fool
7 Spectacular High-Yield Dividend Stocks to Buy in July
These dividend yields could be hotter for investors than the temperatures this month. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
Via Benzinga
Is AbbVie's Dividend Yield Safe?
With biosimilar competition ramping up, the drugmaker's free cash flows are poised to shrink this year. 
Via The Motley Fool
10 Best Stocks to Buy Now, Stock Market News, and Investing Q&A
Where is the stock market headed and which are the best stocks to buy now in an uncertain market? 
Via The Motley Fool
7 Stocks That AI Says Will Make You a Millionaire by 2025
These seven millionaire-maker stocks are changing hands at deeply undervalued levels. As their growth re-accelerates, so will your portfolio. 
Via InvestorPlace
3 Biotech Stocks to Sell Before They Damage Your Portfolio
With the Street generally bearish towards the biotech sector, investors need to identify biotech stocks to avoid at this point. 
Via InvestorPlace
3 Biotech Stocks That AI is Loving in July
As AI becomes a more entrenched aspect of society, investors can lean on these AI recommended biotech stocks with predicted high potential. 
Via InvestorPlace
3 No-Brainer Stocks You Can Buy Right Now
Going with these stocks is an easy decision. 
Via The Motley Fool
The 3 Best Dividend Stocks to Buy in July
Not all stocks pay dividends, and not all dividend payments are equal. Some dividends are more generous than others, and investors seeking to maximize their income need to pay attention to the yield... 
Via InvestorPlace
2 Struggling Dividend Growth Stocks That Could Make You Richer
Let's look beyond these drugmakers' ongoing issues. 
Via The Motley Fool
Why Dividend Stocks Should Be a Key Part of Your Retirement Plan
You can collect the dividend income while keeping your original investment intact. 
Via The Motley Fool
The 7 Best Long-Term Stocks to Buy in July
Although it might not be the most exciting approach, the best long-term stocks in July offer a greater chance of upside success. 
Via InvestorPlace
Got $5,000? These Are 3 of the Best Stocks to Buy in July
There's something here for dividend, value, and growth investors. 
Via The Motley Fool
The 7 Best Forever Stocks to Buy for July 2023
With the market throwing some curveballs, investors may find more confidence engaging the best forever stocks to buy. 
Via InvestorPlace
Meet Chinook Therapeutics, The Company Novartis Is Spending $3.5 Billion To Acquire
Chinook Therapeutics has a history of being opportunistic. Now, it's joining forces with Novartis. 
Via Investor's Business Daily
Protagonist Therapeutics-Janssen Partnered Psoriasis Candidate Fall Short Of Rival Treatment
Protagonist Therapeutics Inc (NASDAQ: PTGX) announced topline results from the Phase 2b FRONTIER 1 trial of the oral interleukin-23 receptor (IL-23R) antagonist JNJ-2113 (formerly PN-235) in adult... 
Via Benzinga
3 Spectacular Dividend Stocks to Buy in July
Heat up your portfolio this month with these dividend stocks. 
Via The Motley Fool
Merck and AbbVie Are Facing Big Patent Cliffs, But Here's Why Both Are Still Buys
Both companies are facing significant patent cliffs, but they've been preparing for this moment. 
Via The Motley Fool
3 Magnificent Dividend Stocks to Buy Hand Over Fist in July
These dividend stocks can add some fireworks to income investors' portfolios. 
Via The Motley Fool
Could This New Drug Be a Blockbuster for These 2 Pharma Collaborators?
In May, the FDA approved epcoritamab, developed by AbbVie and Genmab, as a treatment for a type of blood cancer. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.